Bullboard - Stock Discussion Forum IN8BIO, Inc. INAB

Healthcare Biotechnology

IN8bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell-based immunotherapies for cancer patients. Gamma-delta T cells are a specialized population of T cells that possess properties, including the ability to differentiate between healthy and diseased tissue. The Company's lead program, INB-400,... see more

Add To Watchlist

NDAQ:INAB - Post Discussion

IN8BIO, Inc. > IN8bio Announces Positive INB-200 Phase 1 Data Update in Gli

View:

Post by whytestocks on Jun 05, 2023 7:15pm

IN8bio Announces Positive INB-200 Phase 1 Data Update in Gli

JUST IN: $INAB IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two patients that received three doses remaining progression-free at 23.5 and 19.4 months, respectively. INB-200 continues to exhibit a manageable safety profile with minimal toxicities ...INAB - IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting

126